RT Journal Article
SR Electronic
T1 Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002995
DO 10.1136/jitc-2021-002995
VO 9
IS 10
A1 Lau, Peter Kar Han
A1 Feran, Breon
A1 Smith, Lorey
A1 Lasocki, Arian
A1 Molania, Ramyar
A1 Smith, Kortnye
A1 Weppler, Alison
A1 Angel, Christopher
A1 Kee, Damien
A1 Bhave, Prachi
A1 Lee, Belinda
A1 Young, Richard J
A1 Iravani, Amir
A1 Yeang, Hanxian Aw
A1 Vergara, Ismael A
A1 Kok, David
A1 Drummond, Kate
A1 Neeson, Paul Joseph
A1 Sheppard, Karen E
A1 Papenfuss, Tony
A1 Solomon, Benjamin J
A1 Sandhu, Shahneen
A1 McArthur, Grant A
YR 2021
UL http://jitc.bmj.com/content/9/10/e002995.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.